Generate Biomedicines, Inc. Common Stock (GENB)

Typically moves ±11.14% on earnings
EARNINGS ANALYTICS
search

Generate Biomedicines, Inc. Common Stock (GENB) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -11.14% (May 07, 2026) and its biggest decline was -11.14% (May 07, 2026).

Earnings reactions

How GENB moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±11.14%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 07, 2026 ☀ PRE -11.14% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±11.14%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 7 →
7
Funds holding
$18098151
Total value held
Buying
7 added · 0 reduced
Nvidia Corp
$10416563 NEW BUY
Morgan Stanley
$4216275 NEW BUY
Goldman Sachs Group Inc
$2133688 NEW BUY
Barclays Plc
$886175 NEW BUY
Bank Of America Corp /De/
$427450 NEW BUY

SEC Filing Types

Recent SEC Filings

2 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov

Frequently asked about GENB earnings

How much does GENB stock move after earnings? expand_more

Over 1 reports, GENB has moved an average of ±11.14% the session after earnings, closing higher 0.0% of the time.

What was GENB's biggest post-earnings move? expand_more

GENB's largest post-earnings gain on record was -11.14% on May 07, 2026, and its largest decline was -11.14% on May 07, 2026.

Where can I find Generate Biomedicines, Inc. Common Stock's SEC filings? expand_more

All of Generate Biomedicines, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers